300238 Stock Overview
Develops, manufactures, and sells regenerative medicines and life sciences products primarily in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Guanhao Biotech Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥12.97 |
| 52 Week High | CN¥15.88 |
| 52 Week Low | CN¥7.48 |
| Beta | 0.75 |
| 11 Month Change | 27.78% |
| 3 Month Change | 42.53% |
| 1 Year Change | -6.15% |
| 33 Year Change | -25.46% |
| 5 Year Change | -39.11% |
| Change since IPO | -68.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300238 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 15.6% | 13.2% | 9.9% |
| 1Y | -6.2% | -7.6% | 1.2% |
Return vs Industry: 300238 exceeded the CN Biotechs industry which returned -7.6% over the past year.
Return vs Market: 300238 underperformed the CN Market which returned 1.2% over the past year.
Price Volatility
| 300238 volatility | |
|---|---|
| 300238 Average Weekly Movement | 11.9% |
| Biotechs Industry Average Movement | 7.1% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in CN Market | 9.4% |
| 10% least volatile stocks in CN Market | 4.5% |
Stable Share Price: 300238's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300238's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 535 | Yongming Zhang | www.guanhaobio.com |
Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products primarily in China. It offers NormalGEN, a dura repair patch; GrandNeuro, a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses.
Guanhao Biotech Co.,Ltd. Fundamentals Summary
| 300238 fundamental statistics | |
|---|---|
| Market cap | CN¥3.44b |
| Earnings (TTM) | CN¥20.41m |
| Revenue (TTM) | CN¥383.06m |
168.5x
P/E Ratio9.0x
P/S RatioIs 300238 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300238 income statement (TTM) | |
|---|---|
| Revenue | CN¥383.06m |
| Cost of Revenue | CN¥85.35m |
| Gross Profit | CN¥297.71m |
| Other Expenses | CN¥277.30m |
| Earnings | CN¥20.41m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 29, 2024
| Earnings per share (EPS) | 0.077 |
| Gross Margin | 77.72% |
| Net Profit Margin | 5.33% |
| Debt/Equity Ratio | 14.7% |
How did 300238 perform over the long term?
See historical performance and comparison